1 Podcast Episodes
Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive Non-small Cell Lung Cancer?
Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive Non-small Cell Lung Cancer?
Dr. Joel Neal of Stanford University Medical Center discusses the SELECT clinical trial which studied early stage non-sm... Read more
15 May 2014
•
1min